Interrupted time-series analysis yielded an effect estimate concordant with the cluster-randomized controlled trial result

Journal of Clinical Epidemiology

Volumn 66, Issue 8, 2013, Pages 883-887

  Fretheim, Atle ^a,b,c   Soumerai, Stephen B ^a   Zhang, Fang ^a   Oxman, Andrew D ^b   Ross Degnan, Dennis ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Comparative effectiveness; Evaluation; Health systems; Interrupted time series analysis; Randomized controlled trial; Research methods

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIURETIC AGENT;

ARTICLE; CALCULATION; CONFIDENCE INTERVAL; OBSERVATIONAL STUDY; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TIME SERIES ANALYSIS; TOTAL QUALITY MANAGEMENT;

ANTIHYPERTENSIVE AGENTS; CLUSTER ANALYSIS; DATA INTERPRETATION, STATISTICAL; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FAMILY PRACTICE; GUIDELINE ADHERENCE; HEALTH SERVICES RESEARCH; HUMANS; NORWAY; PHYSICIAN'S PRACTICE PATTERNS; QUALITY IMPROVEMENT; REGRESSION ANALYSIS; TIME FACTORS;

EID: 84879805036     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2013.03.016     Document Type: Article

References (13)

1. M. Gold, D. Helms, and S. Guterman Identifying, monitoring, and assessing promising innovations: using evaluation to support rapid-cycle change Issue Brief (Commonw Fund) 12 2011 1 12
2. P. Craig, P. Dieppe, S. Macintyre, S. Michie, I. Nazareth, and M. Petticrew Developing and evaluating complex interventions: the new Medical Research Council guidance BMJ 337 2008 a1655
3. P. Craig, C. Cooper, D. Gunnell, S. Haw, K. Lawson, and S. Macintyre Using natural experiments to evaluate population health interventions: new Medical Research Council guidance J Epidemiol Community Health 66 2012 1182 1186
4. S. Barber Health system strengthening interventions: making the case for impact evaluation 2007 Alliance for Health Policy and Systems Research Geneva, Switzerland
5. A. Fretheim, A.D. Oxman, J.N. Lavis, and S. Lewin SUPPORT tools for evidence-informed policymaking in health 18: planning monitoring and evaluation of policies Health Res Policy Syst 7 Suppl 1 2009 S18
6. P. Sullivan, and D. Goldmann The promise of comparative effectiveness research JAMA 305 2011 400 401
7. S. Schneeweiss, M. Maclure, B. Carleton, R.J. Glynn, and J. Avorn Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations BMJ 328 2004 560
8. Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective JAMA 307 2012 1636 1640
9. C.R. Ramsay, L. Matowe, R. Grilli, J.M. Grimshaw, and R.E. Thomas Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies Int J Technol Assess Health Care 19 2003 613 623 (Pubitemid 38405635)
10. W.R. Shadish, T.D. Cook, and D.T. Campbell Quasi-experiments: interrupted time-series designs Experimental and quasi-experimental designs for generalized causal inference 2002 Houghton Mifflin Company Boston, MA 171 206
11. A. Fretheim, A.D. Oxman, K. Havelsrud, S. Treweek, D.T. Kristoffersen, and A. Bjorndal Rational prescribing in primary care (RaPP): a cluster randomized trial of a tailored intervention PLoS Med 3 2006 e134
12. O.C. Ukoumunne, and S.G. Thompson Analysis of cluster randomized trials with repeated cross-sectional binary measurements Stat Med 20 2001 417 433 (Pubitemid 32125131)
13. A.K. Wagner, S.B. Soumerai, F. Zhang, and D. Ross-Degnan Segmented regression analysis of interrupted time series studies in medication use research J Clin Pharm Ther 27 2002 299 309 (Pubitemid 34989269)